You are here

Article Text

Article menu

This article has a Reply. Please see:

Download PDFPDF
Correspondence
OCTA, a sensitive screening for asymptomatic retinopathy, raises alarm over systemic involvements in patients with SLE
  1. Yumiko Mizuno1,
  2. Masayuki Nishide1,
  3. Taku Wakabayashi2,
  4. Kohji Nishida2,
  5. Atsushi Kumanogoh1
  1. 1 Department of Respiratory Medicine and Clinical Immunology, Graduate School of Medicine, Osaka University, Suita, Japan
  2. 2 Department of Ophthalmology, Graduate School of Medicine, Osaka University, Suita, Japan
  1. Correspondence to Dr Masayuki Nishide, Department of Respiratory Medicine and Clinical Immunology, Graduate School of Medicine, Osaka University, Suita, Japan; nishide{at}imed3.med.osaka-u.ac.jp

http://dx.doi.org/10.1136/annrheumdis-2018-214751

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    We have read with great interest the letter by Conigliaro et al 1 regarding the usefulness of an optical coherence tomography angiography (OCTA) for evaluating retinal microvasculature in patients with systemic lupus erythematosus (SLE). The authors suggested that OCTA is a sensitive tool to detect preclinical ocular changes, and retinal vascular abnormalities are related to renal involvement in patients with SLE. In addition to this, we wish to emphasise that patients with abnormal eye findings should be closely followed, even if it is asymptomatic and in an early phase, keeping in mind the possibility of neuropsychiatric SLE.

    Previous study showed that patients with SLE with eye involvement often have neuropsychiatric dysfunction as well,2 and we here report a case of asymptomatic retinal …

    View Full Text

    Footnotes

    • Handling editor Josef S Smolen

    • Contributors YM and MN contributed equally to this work. YM examined the patient as the attending physician. TW and KN performed ophthalmological examinations including OCTA. YM, MN and AK wrote the manuscript. All authors contributed to discussion and approved the final version.

    • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

    • Competing interests None declared.

    • Patient consent for publication Obtained.

    • Provenance and peer review Not commissioned; internally peer reviewed.

    Linked Articles